Advanced search
Publication Cover
Current Medical Research and Opinion Volume 26, 2010 - Issue 3
Submit an article Journal homepage
515
Views
26
CrossRef citations to date
0
Altmetric
Original Article

Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers

Kari Linden Pfizer Oy, Helsinki, FinlandCorrespondence[email protected]
,
Vesa Jormanainen Pfizer Oy, Helsinki, Finland (until March 31, 2008)
,
Miika Linna The National Institute for Health and Welfare (THL), Helsinki, Finland
,
Harri Sintonen Department of Public Health, University of Helsinki, Helsinki, Finland
,
Koo Wilson Pfizer Ltd., Walton Oaks, Surrey, UK
&
Teija Kotomäki Pfizer Oy, Helsinki, Finland
Pages 549-560 | Accepted 09 Dec 2009, Published online: 06 Jan 2010

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Kirsi Kautiainen, Heikki Ekroos, Mikko Puhakka, Helena Liira, Juha Laine, Kari Linden & Jarmo Hahl. (2017) Re-treatment with varenicline is a cost-effective aid for smoking cessation. Journal of Medical Economics 20:3, pages 246-252.
Read now
Manfred A. Lutz, Pedro Lovato & Genaro Cuesta. (2012) Cost Analysis of Varenicline Versus Bupropion, Nicotine Replacement Therapy, and Unaided Cessation in Nicaragua. Hospital Practice 40:1, pages 35-43.
Read now
Manfred A. Lutz, Pedro Lovato & Genaro Cuesta. (2012) Cost-Effectiveness Analysis of Varenicline Versus Existing Smoking Cessation Strategies in Central America and the Caribbean Using the BENESCO Model. Hospital Practice 40:1, pages 24-34.
Read now
Jon O Ebbert, Kirk D Wyatt, J Taylor Hays, Eric W Klee & Richard D Hurt. (2010) Varenicline for smoking cessation: efficacy, safety, and treatment recommendations. Patient Preference and Adherence 4, pages 355-362.
Read now

Articles from other publishers (22)

Naira R. Matevosyan. (2021) Healthcare Prometrics in the Era of Redeployment. Journal of the Knowledge Economy 13:2, pages 1374-1413.
Crossref
Ricardo Ribeiro Alves Fernandes, Brayan Viegas Seixas, André Salem Szklo, Renata Leborato Guerra, Laura Augusta Barufaldi, Rita de Cássia Ribeiro de Albuquerque & Cid Manso de Mello Vianna. (2022) Cost-Effectiveness Analysis of Varenicline Versus Currently Funded Smoking Cessation Strategies in Brazil. Value in Health Regional Issues 27, pages 25-31.
Crossref
Richard Dodel, Christopher Kruse, Annette Conrads-Frank & Uwe Siebert. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 101 234 .
Kyla H Thomas, Michael N Dalili, José A López-López, Edna Keeney, David Phillippo, Marcus R Munafò, Matt Stevenson, Deborah M Caldwell & Nicky J Welton. (2021) Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis. Health Technology Assessment 25:59, pages 1-224.
Crossref
Edna Keeney, Nicky J. Welton, Matt Stevenson, Michael N. Dalili, José A. López-López, Deborah M. Caldwell, David M. Phillippo, Marcus R. Munafò & Kyla H. Thomas. (2021) Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events. Value in Health 24:6, pages 780-788.
Crossref
Richard Dodel, Christopher Kruse, Annette Conrads-Frank & Uwe Siebert. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 135 .
Christina S. Kwon, Enrique Seoane-Vazquez & Rosa Rodriguez-Monguio. (2018) Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes. BMC Health Services Research 18:1.
Crossref
Marrit L. Berg, Kei Long Cheung, Mickaël Hiligsmann, Silvia Evers, Reina J. A. Kinderen, Puttarin Kulchaitanaroaj & Subhash Pokhrel. (2017) Model‐based economic evaluations in smoking cessation and their transferability to new contexts: a systematic review. Addiction 112:6, pages 946-967.
Crossref
Shari P. Feirman, Elisabeth Donaldson, Allison M. Glasser, Jennifer L. Pearson, Ray Niaura, Shyanika W. Rose, David B. Abrams & Andrea C. Villanti. (2016) Mathematical Modeling in Tobacco Control Research: Initial Results From a Systematic Review. Nicotine & Tobacco Research 18:3, pages 229-242.
Crossref
Jiraboon Tosanguan & Nathorn Chaiyakunapruk. (2016) Cost-effectiveness analysis of clinical smoking cessation interventions in Thailand. Addiction 111:2, pages 340-350.
Crossref
Jaqueline Scholz, Luana D. Portela, Tania Maria Ogawa Abe, Patricia Viviane Gaya, Valter G. Santos, Cristina Ferreira, Clarice Amorim, Alexandre Costa Pereira & Paulo Caleb Junior Lima Santos. (2016) Cost-effectiveness analysis of smoking-cessation treatment using electronic medical records in a cardiovascular hospital. Clinical Trials and Regulatory Science in Cardiology 14, pages 1-3.
Crossref
Lieven Annemans, Sophie Marbaix, Kristiaan Nackaerts & Pierre Bartsch. (2015) Cost-effectiveness of retreatment with varenicline after failure with or relapse after initial treatment for smoking cessation. Preventive Medicine Reports 2, pages 189-195.
Crossref
고수경, 박다진 & Juyeon Lee. (2014) 금연 치료의 재정영향 분석. The Journal of Health Technology Assessment 2:2, pages 130-136.
Crossref
Aaron Galaznik, Katherine Cappell, Leslie Montejano, Geoffrey Makinson, Kelly H. Zou & Gregory Lenhart. (2014) Impact of Out-of-pocket Costs on Varenicline Utilization and Persistence. Journal of Health Economics and Outcomes Research 2:1, pages 53-62.
Crossref
Vance Rabius, Maher Karam-Hage, Janice A. Blalock & Paul M. Cinciripini. (2014) “Meaningful use” provides a meaningful opportunity. Cancer 120:4, pages 464-468.
Crossref
Kristian Bolin. (2012) Economic Evaluation of Smoking-Cessation Therapies. PharmacoEconomics 30:7, pages 551-564.
Crossref
M. Mahmoudi, C. I. Coleman & D. M. Sobieraj. (2012) Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation. International Journal of Clinical Practice 66:2, pages 171-182.
Crossref
S. Grassin-Delyle & P.-O. Girodet. (2012) Exacerbations dans l’asthme : prévention pharmacologique. Revue des Maladies Respiratoires 29:2, pages 232-244.
Crossref
Antoni Sicras Mainar, Ruth Navarro Artieda, Silvia Díaz Cerezo, Belén Martí Sánchez & Verónica Sanz De Burgoa. (2011) Tasas de abstinencia de vareniclina frente a bupropión y terapia sustitutiva con nicotina en la cesación del tabaco en atención primaria. Atención Primaria 43:9, pages 482-489.
Crossref
Tobias Raupach & Constant P. (Onno) van Schayck. (2011) Pharmacotherapy for Smoking Cessation. CNS Drugs 25:5, pages 371-382.
Crossref
Evelina A. Zimovetz, Koo Wilson, Miny Samuel & Stephen M. Beard. (2011) A review of cost-effectiveness of varenicline and comparison of cost-effectiveness of treatments for major smoking-related morbidities. Journal of Evaluation in Clinical Practice 17:2, pages 288-297.
Crossref
Gillian M. Keating & Katherine A. Lyseng-Williamson. (2010) Pharmacoeconomic Spotlight on Varenicline as an Aid to Smoking Cessation†. CNS Drugs 24:9, pages 797-800.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.